Celcuity Archives - Catalyst Daily

Celcuity ($CELC) stock jumps 12% pre-market on patent exclusivity boost

NewsDesk CD - July 14, 2025 8:02 am

Celcuity (NASDAQ: CELC) stock surged 12.62% in pre-market trading on Monday, July 14, 2025, reaching $15.35 after securing patent on gedatolisib dosing exclusivity through...

Celcuity Inc. ($CELC) Gains Patent Protection for Breast Cancer Drug Gedatolisib

Staff Writer - July 14, 2025 7:20 am

Celcuity Inc. (CELC) has secured U.S. Patent No. 12,350,276, protecting the clinical dosing regimen of its lead drug candidate, gedatolisib, for ER+/HER2- breast cancer...

Brookfield Renewable ($BEP) Commits $1 Billion to Raise Equity in Isagen...

July 18, 2025 4:45 pm

FONAR ($FONR) Jumps 3% After-Hours to $16.40 on Acquisition Buzz

July 18, 2025 4:33 pm

FONAR Corporation ($FONR) Confirms Receipt of Supplemental Offer from Timothy Damadian...

July 18, 2025 4:29 pm

Tag: Celcuity

Celcuity ($CELC) stock jumps 12% pre-market on patent exclusivity boost

Celcuity Inc. ($CELC) Gains Patent Protection for Breast Cancer Drug Gedatolisib

Brookfield Renewable ($BEP) Commits $1 Billion to Raise Equity in Isagen...

FONAR ($FONR) Jumps 3% After-Hours to $16.40 on Acquisition Buzz

FONAR Corporation ($FONR) Confirms Receipt of Supplemental Offer from Timothy Damadian...